Sorg Elaine K.'s Form 4 filing
AbbVie Inc. (ABBV) · filed Apr 19, 2023
- Accession no.
- 0001415889-23-006720
- Filed
- Apr 19, 2023
- Trade date
- Apr 17, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.21M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sorg Elaine K.CIK 0001832571 | Officer (SVP, US COMMERCIAL OPERATIONS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | Common Stock, $0.01 par value | SSaleDisposed | −6,999 | $161.64 | −$1,131,318.36 | 35,830 | Direct | |
| Apr 17, 2023 | Common Stock, $0.01 par value | SSaleDisposed | −500 | $162.04 | −$81,020 | 35,330 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.